NPAS4 Antibody

What is NPAS4 and why is it important in research?

NPAS4 (Neuronal PAS domain protein 4) is a basic helix-loop-helix transcription factor belonging to the PAS domain family, which includes other important factors such as Arnt, Clock, BmalI, and Hif1a. The protein is approximately 87.1 kilodaltons in mass and is encoded by the NPAS4 gene (also known as Le-PAS, PASD10) in humans .

NPAS4 functions as an immediate early gene (IEG) that is rapidly upregulated in response to cellular activity without requiring new protein synthesis. It plays crucial roles in:

• Activity-dependent regulation in neurons

• Cytoprotection in pancreatic β-cells

• Stress response mechanisms

• Transcriptional regulation of downstream genes

Its importance lies in its ability to translate external signals to functional changes within cells, particularly in response to stress conditions, making it a valuable research target for understanding cellular homeostasis mechanisms .

What are the validated applications for NPAS4 antibodies?

Based on current research, NPAS4 antibodies have been validated for several applications including:

• Western Blot (WB): Detection of ~90 kDa Npas4 protein, with potential additional bands at ~60, 45, 40, 38, 25, and 20 kDa

• Immunohistochemistry (IHC): Visualization of NPAS4 protein in tissue sections

• Enzyme-Linked Immunosorbent Assay (ELISA): Quantification of NPAS4 protein

• Immunocytochemistry (ICC)/Immunofluorescence: Cellular localization of NPAS4

When performing IHC and ICC experiments, researchers should note that Mouse-On-Mouse blocking reagents may be necessary to reduce high background signal when using mouse monoclonal antibodies on mouse tissues .

What is the expression pattern of NPAS4 in different tissues?

While initially considered brain-specific, research has demonstrated that NPAS4 is expressed in multiple tissues:

• Neural tissues: Originally characterized in neurons where it is activity-regulated

• Pancreatic islets: Expressed in β-cells where it responds to glucose-mediated depolarization

• Other species expression: Orthologs may be found in canine, porcine, monkey, mouse, and rat tissues

Expression is typically low under basal conditions but can be rapidly induced by:

• Membrane depolarization

• Calcium influx

• Endoplasmic reticulum (ER) stress

• Other cellular stressors

This expression pattern makes NPAS4 a valuable marker for studying activity-dependent transcriptional responses across different cell types .

How should NPAS4 antibodies be validated before experimental use?

Thorough validation of NPAS4 antibodies is essential for reliable results:

• Specificity testing:

  • Western blot analysis with recombinant NPAS4 protein

  • Comparison with known positive controls (e.g., stimulated neurons or β-cells)

  • Testing in knockout/knockdown models to confirm specificity

• Cross-reactivity assessment:

  • Testing across species if working with non-human models

  • Evaluating against related PAS domain family proteins

• Application-specific validation:

  • Optimizing antibody concentration for each technique (WB, IHC, ICC)

  • Confirming expected molecular weight (~90 kDa) in Western blots

  • Testing in known NPAS4-expressing tissues like brain or pancreatic islets

• Positive controls:

  • Using KCl-depolarized neuronal cells or glucose-stimulated β-cells that upregulate NPAS4

How can NPAS4 antibodies be utilized to study activity-dependent gene regulation?

Activity-dependent gene regulation studies using NPAS4 antibodies can employ several sophisticated approaches:

• Chromatin immunoprecipitation (ChIP) assays:

  • NPAS4 antibodies can be used to identify direct binding sites on DNA after cellular stimulation

  • Research has demonstrated that NPAS4 binds to the enhancer and intron 1 of the Rgs2 gene with 22-fold and 3-fold enrichment, respectively, after 2 hours of depolarization

  • ChIP-seq can be performed to identify genome-wide binding sites

• Time-course experiments:

  • Tracking NPAS4 induction with temporal resolution (15 min to 4 hrs post-stimulation)

  • Correlating NPAS4 expression with downstream target gene activation (like Rgs2)

  • Comparison with other IEGs to establish regulatory networks

• Cellular compartmentalization studies:

  • Using fractionation followed by western blotting to track NPAS4 translocation

  • Immunofluorescence to visualize nuclear accumulation upon activation

• Activity-dependent promoter studies:

  • Utilize reporter assays with potential NPAS4 binding sites

  • Validate direct transcriptional regulation of targets like insulin promoter

What methodologies are effective for studying NPAS4's role in cellular stress response?

To investigate NPAS4's cytoprotective functions in stress response:

• Induction protocols:

  • KCl depolarization (40 mM) to induce NPAS4 in both neuronal cells and β-cells

  • Glucose stimulation (16 mM) for β-cells

  • Classical ER stressors like thapsigargin and palmitate

• Loss/gain-of-function approaches:

  • Adenoviral vectors for Npas4 overexpression (Ad-Npas4)

  • siRNA knockdown to reduce endogenous Npas4 levels

  • CRISPR/Cas9 gene editing for knockout models

• Stress response assessment:

  • Measure unfolded protein response (UPR) markers (Ddit3, Xbp1 splicing)

  • Monitor chaperone induction (Hspa5)

  • Quantify cell death using annexin V/PI staining or TUNEL assays

• Downstream target analysis:

  • qRT-PCR and western blot for Rgs2 and MafA expression

  • Functional assays for cAMP production

  • Insulin content and secretion measurements

What are the technical considerations when using NPAS4 antibodies for detecting rapid changes in expression levels?

Detecting the dynamic expression of NPAS4 requires careful technical considerations:

• Temporal resolution optimization:

  • Design time-course experiments with sufficient early time points (15, 30, 60, 120 min)

  • Use translational inhibitors (cycloheximide) to confirm IEG status

  • Consider pulse-chase experiments for protein turnover analysis

• Sample preparation protocols:

  • Rapid fixation to capture transient expression

  • Optimized lysis buffers for complete protein extraction

  • Protease inhibitors to prevent degradation during processing

• Detection sensitivity enhancement:

  • Signal amplification methods for low abundance detection

  • Chemiluminescent substrates with extended dynamic range for western blots

  • Tyramide signal amplification for immunostaining of tissues with low expression

• Quantification approaches:

  • Digital image analysis with appropriate controls

  • Normalization to housekeeping proteins

  • Standard curves with recombinant proteins for absolute quantification

How can researchers distinguish between specific NPAS4 signal and non-specific binding in complex tissue samples?

Distinguishing specific from non-specific signals requires rigorous controls:

• Blocking optimization:

  • Mouse-On-Mouse blocking reagents when using mouse monoclonal antibodies on mouse tissues

  • Titration of primary antibody concentrations

  • Extended blocking times with appropriate blocking agents

• Multiple detection methods:

  • Parallel analysis with antibodies targeting different epitopes

  • Correlation of protein detection with mRNA expression

  • Comparison of results across multiple techniques (WB, IHC, ICC)

• Knockout/knockdown validation:

  • Negative controls using NPAS4 knockout tissues

  • siRNA-treated samples to show signal reduction

  • Peptide competition assays to demonstrate specificity

• Expected band pattern analysis:

  • Primary band at ~90 kDa for full-length NPAS4

  • Understanding potential additional bands (~60, 45, 40, 38, 25, 20 kDa) that may represent splice variants or degradation products

What are the optimal stimulation protocols for inducing NPAS4 expression in different cell types?

Different cell types require tailored stimulation protocols for optimal NPAS4 induction:

For all protocols:

• Include calcium channel blockers (nifedipine) in parallel experiments to confirm calcium-dependence

• Monitor cellular viability as excessive stimulation may induce apoptosis

• Consider pre-treatments with cycloheximide to confirm IEG status

• Use qRT-PCR to monitor mRNA induction before protein detection

How should researchers troubleshoot inconsistent NPAS4 detection across experiments?

When facing inconsistent NPAS4 detection, consider this systematic troubleshooting approach:

• Antibody-related factors:

  • Verify antibody lot consistency

  • Test storage conditions (avoid freeze-thaw cycles)

  • Optimize concentration for each application

  • Consider alternative antibodies targeting different epitopes

• Sample preparation issues:

  • Standardize stimulation protocols

  • Ensure rapid sample processing to capture transient expression

  • Optimize protein extraction methods (RIPA vs. gentler buffers)

  • Add protease inhibitors immediately after collection

• Technical parameters:

  • For WB: optimize transfer conditions for high molecular weight proteins

  • For IHC/ICC: test multiple antigen retrieval methods

  • For all methods: standardize blocking conditions and incubation times

  • Consider species cross-reactivity issues

• Biological variables:

  • Account for circadian variations in expression

  • Standardize cell confluence/density in cultures

  • Control for passage number in cell lines

  • Consider variations in basal activity levels

What experimental designs effectively demonstrate NPAS4's functional roles in cellular protection?

To establish NPAS4's cytoprotective functions:

• Gain-of-function studies:

  • Adenoviral or lentiviral NPAS4 overexpression

  • Challenge with ER stressors (thapsigargin, palmitate)

  • Measure cell viability, apoptosis markers, and UPR activation

  • Compare stress responses between NPAS4-expressing and control cells

• Loss-of-function approaches:

  • siRNA knockdown of endogenous NPAS4

  • CRISPR/Cas9 knockout models

  • Dominant-negative NPAS4 constructs

  • Assess vulnerability to stress conditions

• Pathway analysis:

  • Monitor downstream targets (Rgs2, MafA)

  • Assess UPR markers (Ddit3, Xbp1 splicing, Hspa5, Wfs-1)

  • Measure functional outcomes (insulin content, cAMP production)

  • Perform rescue experiments to confirm specificity

• In vivo relevance:

  • Tissue-specific NPAS4 modulation

  • Physiological and pathological stress models

  • Correlation with disease progression markers

How can researchers effectively investigate the relationship between NPAS4 and other stress-response pathways?

To study NPAS4's interaction with broader stress response networks:

• Co-expression analysis:

  • Simultaneous detection of NPAS4 and UPR markers

  • Time-course correlation between NPAS4 and stress response genes

  • Single-cell analysis to identify cellular subpopulations

• Pathway manipulation:

  • Combined overexpression/knockdown experiments

  • Chemical modulators of stress pathways (PERK inhibitors, IRE1 modulators)

  • Genetic models with altered stress response components

• Protein-protein interactions:

  • Co-immunoprecipitation with NPAS4 antibodies

  • Proximity ligation assays to detect in situ interactions

  • Mammalian two-hybrid or BiFC to confirm direct interactions

• Integrative multi-omics:

  • ChIP-seq for genome-wide binding sites

  • RNA-seq to assess global transcriptional effects

  • Proteomics to identify post-translational modifications and interaction partners

  • Data integration to construct comprehensive regulatory networks

How can NPAS4 antibodies be applied to study its role in diabetes and β-cell dysfunction?

NPAS4 antibodies enable several specialized approaches for diabetes research:

• β-cell stress response mechanisms:

  • Immunohistochemical analysis of NPAS4 expression in diabetic vs. healthy pancreatic samples

  • Correlation of NPAS4 levels with markers of β-cell stress and apoptosis

  • Time-course analysis during diabetes progression in animal models

• Therapeutic target validation:

  • NPAS4 modulation in β-cells followed by functional assessment

  • Monitoring effects on insulin content and glucose-stimulated insulin secretion

  • Assessing protection against lipotoxicity and glucotoxicity

  • Determining impact on incretin responsiveness through GLP-1 potentiation tests

• Mechanistic studies:

  • Investigation of NPAS4's inhibitory interaction with the insulin promoter

  • Analysis of Rgs2 induction and subsequent effects on cAMP signaling

  • Evaluation of NPAS4's role in regulating ER stress markers (Ddit3, Xbp1)

  • Assessment of MafA induction as a mediator of cytoprotection

• Translational approaches:

  • Screening compounds that modulate NPAS4 expression

  • Developing interventions that mimic NPAS4's protective effects

  • Biomarker studies correlating NPAS4 levels with disease progression

What is the optimal methodology for using NPAS4 antibodies in chromatin immunoprecipitation studies?

For successful NPAS4 ChIP experiments:

• Stimulation protocol optimization:

  • Determine peak nuclear NPAS4 expression (typically 1-2 hours post-stimulation)

  • Use appropriate stimuli (KCl, glucose, or other depolarizing agents)

  • Include unstimulated controls for background assessment

• Cross-linking and chromatin preparation:

  • 1% formaldehyde for 10-15 minutes at room temperature

  • Glycine quenching followed by cell lysis

  • Sonication to achieve 200-500 bp fragments

  • Verify fragmentation by agarose gel electrophoresis

• Immunoprecipitation guidelines:

  • Pre-clear chromatin with protein A/G beads

  • Use 3-5 μg of validated ChIP-grade NPAS4 antibody per reaction

  • Include appropriate controls (IgG, input samples)

  • Perform overnight incubation at 4°C with rotation

• Target site analysis:

  • qPCR for suspected binding sites (e.g., Rgs2 enhancer, intron 1)

  • Primer design for promoter regions of interest

  • ChIP-seq for genome-wide binding profile

  • Data analysis with appropriate peak calling algorithms

How can researchers quantitatively assess NPAS4 protein expression dynamics in response to different stimuli?

For quantitative analysis of NPAS4 expression dynamics:

• Western blot quantification:

  • Use fluorescent secondary antibodies for wider linear range

  • Include recombinant NPAS4 standards for absolute quantification

  • Analyze band intensities with specialized software

  • Normalize to total protein loading (REVERT or similar technologies)

• High-content imaging approaches:

  • Automated immunofluorescence microscopy

  • Single-cell analysis of nuclear NPAS4 accumulation

  • Time-lapse imaging for real-time dynamics

  • Quantification of nuclear/cytoplasmic ratio changes

• Flow cytometry applications:

  • Intracellular staining protocols for NPAS4

  • Multi-parameter analysis with other stress markers

  • Kinetic studies across multiple time points

  • Statistical analysis of population distributions

• Advanced methodologies:

  • Bioluminescence resonance energy transfer (BRET) with NPAS4-luciferase constructs

  • Fluorescence recovery after photobleaching (FRAP) with NPAS4-GFP

  • Single-molecule tracking for protein dynamics

  • Mass spectrometry for absolute quantification

What are the critical considerations when comparing NPAS4 expression across different species and tissue types?

When conducting cross-species and cross-tissue NPAS4 research:

• Antibody validation across species:

  • Verify epitope conservation in target species

  • Conduct Western blots to confirm expected molecular weight

  • Validate with recombinant proteins from each species

  • Consider species-specific antibodies when necessary

• Experimental design adaptations:

  • Adjust stimulation protocols for tissue-specific responses

  • Account for differences in NPAS4 induction thresholds

  • Control for baseline expression variations

  • Consider developmental and age-related differences

• Tissue-specific protein extraction:

  • Optimize extraction buffers for different tissues

  • Adjust homogenization methods for tissue density

  • Consider native tissue activity states (e.g., pancreas vs. brain)

  • Add tissue-specific protease inhibitor cocktails

• Interpretation guidelines:

  • Recognize potential functional differences across species/tissues

  • Account for post-translational modifications

  • Consider splice variants and tissue-specific isoforms

  • Use orthogonal methods to validate unexpected findings

What strategies help resolve contradictory results when using different NPAS4 antibodies?

When facing contradictory results with different NPAS4 antibodies:

• Epitope mapping and comparison:

  • Identify the exact epitopes recognized by each antibody

  • Assess potential post-translational modifications that might affect epitope recognition

  • Consider potential splice variants or proteolytic processing

  • Test with recombinant full-length and truncated NPAS4 proteins

• Validation with orthogonal methods:

  • Correlate protein detection with mRNA expression (qRT-PCR)

  • Use genetic approaches (overexpression, knockdown) to confirm specificity

  • Apply mass spectrometry to identify detected proteins

  • Perform peptide competition assays

• Application-specific optimization:

  • Different antibodies may perform optimally in different applications

  • Test each antibody across multiple experimental conditions

  • Adjust protocols specifically for each antibody

  • Document performance characteristics systematically

• Collaborative resolution:

  • Compare results with published literature

  • Consult with antibody manufacturers for technical support

  • Consider round-robin testing with other laboratories

  • Report findings to improve community knowledge

How should researchers interpret complex band patterns in Western blots using NPAS4 antibodies?

For accurate interpretation of Western blot band patterns:

• Expected pattern analysis:

  • Primary band at ~90 kDa for full-length NPAS4

  • Additional bands may appear at ~60, 45, 40, 38, 25, and 20 kDa

  • Consider potential splice variants, proteolytic fragments, or post-translational modifications

• Validation approach:

  • Run recombinant NPAS4 as size control

  • Include stimulated and unstimulated samples

  • Test tissues from knockout animals as negative controls

  • Use multiple antibodies targeting different epitopes

• Band identity confirmation:

  • Immunoprecipitation followed by mass spectrometry

  • RNA interference to determine which bands decrease

  • Overexpression studies to identify increased bands

  • Time-course studies to track appearance of fragments

• Technical considerations:

  • Optimize sample preparation to minimize degradation

  • Test different extraction methods and buffer compositions

  • Adjust gel percentage for optimal separation

  • Consider gradient gels for resolving multiple bands

What are the best practices for analyzing co-localization of NPAS4 with other proteins in multi-label immunofluorescence studies?

For rigorous co-localization analysis:

• Experimental design:

  • Select antibodies raised in different host species

  • Include appropriate single-label controls

  • Prepare samples with known co-localization patterns as positive controls

  • Use knockout/knockdown samples as negative controls

• Image acquisition parameters:

  • Optimize signal-to-noise ratio for each channel

  • Avoid bleed-through by sequential scanning

  • Maintain consistent settings across all samples

  • Capture z-stacks for 3D co-localization analysis

• Quantitative analysis:

  • Calculate Pearson's or Mander's correlation coefficients

  • Perform object-based co-localization analysis

  • Use specialized software like JACoP, Coloc2, or CellProfiler

  • Report both visual and statistical co-localization measures

• Advanced approaches:

  • Super-resolution microscopy for sub-diffraction co-localization

  • FRET analysis for direct protein-protein interactions

  • Proximity ligation assay for detecting close associations

  • Live-cell imaging to track dynamic co-localization

How can researchers differentiate between specific and non-specific effects when manipulating NPAS4 expression in functional studies?

To distinguish specific from non-specific effects:

• Control strategies:

  • Include multiple control conditions (empty vector, scrambled siRNA)

  • Use rescue experiments with wild-type NPAS4

  • Test mutant NPAS4 constructs lacking functional domains

  • Compare effects across different cell types

• Dose-dependency assessment:

  • Perform titration experiments with varying NPAS4 levels

  • Correlate functional outcomes with expression levels

  • Determine minimum effective concentration

  • Establish dose-response relationships

• Temporal analysis:

  • Track time course of both NPAS4 expression and functional outcomes

  • Use inducible expression systems to control timing

  • Determine lag periods between expression and effects

  • Assess reversibility upon expression cessation

• Pathway validation:

  • Target known downstream effectors (Rgs2, MafA)

  • Use pathway inhibitors to block specific signaling routes

  • Perform epistasis experiments with pathway components

  • Compare gene expression profiles between specific and non-specific interventions